The Aura Strategy Logo
The Aura Strategy Logo

What is LL-37?

Research Focus: Immune, Tissue Repair, Wounds

Benefits, Research & Legality (2025 Guide)

LL-37 is the only cathelicidin peptide found in humans. It is a broad-spectrum antimicrobial peptide and a key component of the innate immune system, studied for its powerful immune-modulating and wound-healing effects.

At a Glance

LL-37 is released by immune cells and epithelial cells in response to infection or injury. It directly kills pathogens and also acts as a signaling molecule to recruit immune cells and promote tissue repair. This section provides a general overview of its research context.

About LL-37

LL-37 is released by immune cells and epithelial cells in response to infection or injury. It directly kills pathogens and also acts as a signaling molecule to recruit immune cells and promote tissue repair.

How It Works

Direct Antimicrobial Action

Disrupts the membranes of bacteria, viruses, and fungi.

Immune Modulation

Regulates the inflammatory response, promoting healing while fighting infection.

Angiogenesis and Epithelialization

Promotes the formation of new blood vessels and the growth of new skin cells, accelerating wound closure.

Current Research Insights

Innate Immunity Booster

LL-37 is a major focus in research for developing new strategies against antibiotic-resistant bacteria and chronic wounds.

Areas of Study

Chronic Wounds and Burns

Investigated for accelerating healing and preventing infection.

Autoimmune and Inflammatory Diseases

Studied for its ability to modulate the immune system.

Infections

Researching its broad-spectrum activity against various pathogens.

Research Use Only Section

LL-37 is strictly intended for laboratory and clinical research:

  • Available exclusively from authorized research suppliers
  • Not FDA-approved for general therapeutic use
  • Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation

FAQs

Research

  • Studies on LL-37's role in innate immunity and antimicrobial defense.
  • Research into the wound healing and angiogenic properties of cathelicidins.

(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)